RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-3.89%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.3B
AUM Growth
+$2.3B
(-5.7%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
80
New
11
Increased
12
Reduced
36
Closed
4
Top Buys
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$40.1M |
| 2 |
DexCom
DXCM
|
$39M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$32.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
$31.9M |
| 5 |
Bristol-Myers Squibb
BMY
|
$31.2M |
Top Sells
| 1 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$38.9M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$37M |
| 3 |
Pliant Therapeutics
PLRX
|
$25.3M |
| 4 |
Akero Therapeutics
AKRO
|
$22.5M |
| 5 |
Amicus Therapeutics
FOLD
|
$21.1M |
Sector Composition
| 1 | Healthcare | 98.78% |
| 2 | Industrials | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
RAPT Therapeutics
RAPT
$187M
| $12.6M | 0.55% |
688,132
-96,700
| -12% | -$1.77M |
|
|
ALLK
52
DELISTED
Allakos
ALLK
| $10.2M | 0.44% |
2,286,177
-259,098
| -10% | -$1.15M |
|
|
MDVL
53
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $9.92M | 0.43% |
34,604,516
| – | – |
|
54
Boston Scientific
BSX
$159B
| $8.59M | 0.37% |
+171,780
| New | +$8.59M |
|
55
Illumina
ILMN
$15.2B
| $7.79M | 0.34% |
+33,496
| New | +$7.79M |
|
|
KLRS
56
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $7.52M | 0.33% |
1,907,969
| – | – |
|
|
SNCE
57
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $5.58M | 0.24% |
19,808,234
| – | – |
|
58
Grifois
GRFS
$6.53B
| $5.31M | 0.23% |
720,784
+395,184
| +121% | +$2.91M |
|
59
Nuvation Bio
NUVB
$1.08B
| $5.03M | 0.22% |
3,031,009
| – | – |
|
|
SLGC
60
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $4.77M | 0.21% |
1,870,839
+370,839
| +25% | +$946K |
|
61
LAVA Therapeutics
LVTX
$41.3M
| $3.44M | 0.15% |
2,074,372
-741,824
| -26% | -$1.23M |
|
|
NVTA
62
DELISTED
Invitae Corporation
NVTA
| $3.08M | 0.13% |
2,280,403
| – | – |
|
63
Stereotaxis
STXS
$246M
| $3.03M | 0.13% |
1,487,495
| – | – |
|
64
ALX Oncology
ALXO
$54.6M
| $2.65M | 0.12% |
586,977
-20,493
| -3% | -$92.6K |
|
65
Cabaletta Bio
CABA
$144M
| $2.27M | 0.1% |
274,252
-190,000
| -41% | -$1.57M |
|
|
HOOK
66
DELISTED
HOOKIPA Pharma
HOOK
| $1.88M | 0.08% |
2,552,949
-561,819
| -18% | -$413K |
|
67
Invivyd
IVVD
$218M
| $1.73M | 0.08% |
1,440,725
| – | – |
|
68
Xeris Biopharma Holdings
XERS
$1.27B
| $1.71M | 0.07% |
1,046,587
| – | – |
|
|
ACHL
69
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $1.54M | 0.07% |
1,608,089
| – | – |
|
70
Neurogene
NGNE
$284M
| $1.29M | 0.06% |
1,847,600
-2,966
| -0.2% | -$2.07K |
|
71
Alpha Teknova
TKNO
$227M
| $1.1M | 0.05% |
373,244
-184,855
| -33% | -$547K |
|
|
SONX
72
DELISTED
Sonendo, Inc.
SONX
| $996K | 0.04% |
498,131
| – | – |
|
|
TCRR
73
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $988K | 0.04% |
658,336
-73,043
| -10% | -$110K |
|
74
Cytosorbents Corp
CTSO
$61.5M
| $612K | 0.03% |
181,639
-84,726
| -32% | -$286K |
|
|
BCEL
75
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $505K | 0.02% |
442,653
| – | – |
|